Related Experiment Video
Updated: Jun 2, 2026
15:43
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Published on: March 17, 2014
Genetics of complex airway disease
William O C Cookson1, Miriam F Moffatt
1National Heart and Lung Institute, London SW3 6LY, UK. w.cookson@imperial.ac.uk
Proceedings of the American Thoracic Society
|May 6, 2011
Summary
Recent genetic studies have uncovered significant links to complex airway diseases like asthma and COPD. Much genetic susceptibility remains undiscovered, highlighting the need for further research into these common conditions.
Area of Science:
- Genetics and Respiratory Medicine
- Genomics and Complex Diseases
Background:
- Significant genetic effects for common complex diseases, including asthma and chronic obstructive pulmonary disease (COPD), have been identified in recent years.
- Current understanding suggests only a fraction of genetic susceptibility to these conditions has been discovered, indicating substantial room for further investigation.
Purpose of the Study:
- To review findings from genome-wide association studies (GWAS) for asthma.
- To provide an overview of ongoing large-scale studies for chronic obstructive pulmonary disease (COPD).
- To discuss the future implications of advanced technologies in genetic and epigenetic research for airway diseases.
Main Methods:
- Review of genome-wide association studies (GWAS) for asthma.
- Overview of parallel large-scale studies for chronic obstructive pulmonary disease (COPD).
- Discussion of emerging technologies including gene expression studies, next-generation sequencing, and genome-wide epigenetic analysis.
Main Results:
- Identification of significant genetic effects contributing to asthma and COPD.
- Highlighting the substantial portion of genetic susceptibility yet to be uncovered for complex airway diseases.
- Demonstrating the growing scale and impact of genetic research in respiratory medicine.
Conclusions:
- Genetic research has significantly advanced the understanding of asthma and COPD.
- Future technological advancements promise deeper insights into the genetic and epigenetic underpinnings of airway diseases.
- Genetic technologies are increasingly being applied to study the airway microbiota and its role in respiratory health and disease.
Related Concept Videos
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:23Cystic Fibrosis: Pathogenesis
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation